Abstract Objective To study the changes of minimal residual disease (MRD) in children with B cell acute lymphoblastic leukemia (B-ALL) of different genetic abnormalities. Methods Between February 2004 and April 2013, 271 newly diagnosed B-ALL pediatric patients who had finished the induction chemotherapy were enrolled in the study. The characteristics of changes in MRD in patients with different genetic abnormalities on the 15th day and at the end of the induction therapy were analyzed. Results On the 15th day of the induction chemotherapy, the MRD positive proportion in patients with hyperdiploid was higher on all the three cut-off levels of MRD≥0.1%, 1% and 10% compared to patients without hyperdiploid (PP>0.05). On the end of induction chemotherapy, there was no significant difference in the MRD positive proportion on the three levels of MRD between the patients with and without hyperdiploid (P>0.05), neither between the BCR-ABL-positive and negative groups. The MRD positive proportion in TEL-AML1-negative patients was significantly higher than in TEL-AML1-positive patients on all three levels of MRD (PPConclusions Children with B-ALL of different genetic abnormalities have different MRD levels during, and at the end of, induction therapy. The prognostic significance of MRD may be related to the genetic abnormalities.
HUANG Shan-Ya-Mei,JIA Yue-Ping,LIU Gui-Lan et al. A comparison of minimal residual disease in children with acute lymphoblastic leukemia of different genetic abnormalities[J]. CJCP, 2014, 16(5): 494-498.
HUANG Shan-Ya-Mei,JIA Yue-Ping,LIU Gui-Lan et al. A comparison of minimal residual disease in children with acute lymphoblastic leukemia of different genetic abnormalities[J]. CJCP, 2014, 16(5): 494-498.
Kajsa P, Erik F, Henrik L, et al. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia[J]. Proc Natl Acad Sci USA, 2010, 107(50): 21719-21724.
[24]
Moorman AV, Ensor HM, Richards SM, et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial[J]. Lancet Oncol, 2010, 11(5): 429-438.
[1]
Soriano-Guillen L, Corripio R, Labarta JI, et al. Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigratio[J]. Clin Endocrinol Metab, 2010, 95(9): 4305-4313.
[25]
Kager L, Lion T, Attarbaschi A, et al. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children[J]. Haematologica, 2007, 92(11): 1561-1564.
[26]
Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia[J]. Blood Rev, 2012, 26(3): 123-135.
